Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caredx Inc (NQ: CDNA )

7.900 -0.490 (-5.84%)
Streaming Delayed Price Updated: 11:31 AM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 182,858
Open 8.400
Bid (Size) 7.880 (1)
Ask (Size) 7.900 (1)
Prev. Close 8.390
Today's Range 7.830 - 8.410
52wk Range 6.220 - 27.35
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress
From CareDx, Inc.
Via Business Wire
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire

Performance

YTD
-28.83%
-28.83%
1 Month
-3.78%
-3.78%
3 Month
-26.06%
-26.06%
6 Month
-39.51%
-39.51%
1 Year
-69.89%
-69.89%

More News

Read More
CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum
From CareDx, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Recap: CareDx Q1 Earnings
Via Benzinga
CareDx Reports First Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
A Preview Of CareDx's Earnings
Via Benzinga
Analyst Expectations for CareDx's Future
Via Benzinga
CareDx Earns Stock Downgrade Amid CMS Coverage Cuts Change Thesis
Via Benzinga
CareDx to Report First Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference
From CareDx, Inc.
Via Business Wire
CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation
From CareDx, Inc.
Via Business Wire
National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community
From CareDx, Inc.
Via Business Wire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From CareDx, Inc.
Via Business Wire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From Miromatrix Medical Inc.
Via GlobeNewswire
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
From CareDx, Inc.
Via Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance
From CareDx, Inc.
Via Business Wire
CareDx Update Regarding Raymond James & Associates’ Conference
From CareDx, Inc.
Via Business Wire
Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
Via Benzinga
CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.